Myelodysplastic syndromes (MDS) are a heterogeneous group of hematological malignancies characterized by peripheral blood cytopenia and abnormal myeloproliferation, as well as a variable risk of evolution into acute myeloid leukemia (AML). The nucleus is a highly organized organelle with several distinct domains where nuclear inositides localize to mediate essential cellular events. Nuclear inositides play a critical role in the modulation of erythropoiesis or myelopoiesis. Here, we briefly review the nuclear structure, the localization of inositides and their metabolic enzymes in subnuclear compartments, and the molecular aspects of nuclear inositides in MDS.

Xian, J., Owusu Obeng, E., Ratti, S., Rusciano, I., Marvi, M.V., Fazio, A., et al. (2020). Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes. CELLS, 9(3), 1-15 [10.3390/cells9030697].

Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes

Xian, Jie;Owusu Obeng, Eric;Ratti, Stefano;Rusciano, Isabella;Marvi, Maria Vittoria;Fazio, Antonietta;De Stefano, Alessia;Mongiorgi, Sara;Cappellini, Alessandra;Ramazzotti, Giulia;Manzoli, Lucia;Cocco, Lucio
;
Follo, Matilde Yung
2020

Abstract

Myelodysplastic syndromes (MDS) are a heterogeneous group of hematological malignancies characterized by peripheral blood cytopenia and abnormal myeloproliferation, as well as a variable risk of evolution into acute myeloid leukemia (AML). The nucleus is a highly organized organelle with several distinct domains where nuclear inositides localize to mediate essential cellular events. Nuclear inositides play a critical role in the modulation of erythropoiesis or myelopoiesis. Here, we briefly review the nuclear structure, the localization of inositides and their metabolic enzymes in subnuclear compartments, and the molecular aspects of nuclear inositides in MDS.
2020
Xian, J., Owusu Obeng, E., Ratti, S., Rusciano, I., Marvi, M.V., Fazio, A., et al. (2020). Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes. CELLS, 9(3), 1-15 [10.3390/cells9030697].
Xian, Jie; Owusu Obeng, Eric; Ratti, Stefano; Rusciano, Isabella; Marvi, Maria Vittoria; Fazio, Antonietta; De Stefano, Alessia; Mongiorgi, Sara; Capp...espandi
File in questo prodotto:
File Dimensione Formato  
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 2.38 MB
Formato Adobe PDF
2.38 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/763593
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 10
social impact